Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.43 |
| ▸ | GSK3B | P49841 | 1/20 | 0.43 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.35 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.35 |
| ▸ | NPBWR1 | P48145 | 2/20 | 0.34 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.33 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.33 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.33 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22197877 | 0.84 | GSK3A (0.47) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5535450 | 0.82 | GSK3A (0.47) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL17995365 | 0.81 | GSK3A (0.45) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL25965011 | 0.80 | GSK3A (0.44) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL29328204 | 0.78 | GSK3A (0.45) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5533650 | 0.72 | GSK3A (0.42) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL5575888 | 0.72 | NPBWR1 (0.43) | GSK3AGSK3BTRPV1PTGS2NPBWR1 | |
| SCHEMBL25629292 | 0.70 | GSK3A (0.30) | GSK3AGSK3B | |
| SCHEMBL5531699 | 0.70 | CA12 (0.50) | GSK3AGSK3BTRPV1MPIPHOSPHO1 | |
| SCHEMBL17537378 | 0.68 | GSK3A (0.59) | GSK3AGSK3BTRPV1MPIPHOSPHO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230174502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2023-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PAX2, PAX3, HPRT1 | GSK3A 2364/4885GSK3B 2549/4885TRPV1 474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.